Literature DB >> 10428026

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

M D Sternlicht1, A Lochter, C J Sympson, B Huey, J P Rougier, J W Gray, D Pinkel, M J Bissell, Z Werb.   

Abstract

Matrix metalloproteinases (MMPs) are invariably upregulated in the stromal compartment of epithelial cancers and appear to promote invasion and metastasis. Here we report that phenotypically normal mammary epithelial cells with tetracycline-regulated expression of MMP3/stromelysin-1 (Str1) form epithelial glandular structures in vivo without Str1 but form invasive mesenchymal-like tumors with Str1. Once initiated, the tumors become independent of continued Str1 expression. Str1 also promotes spontaneous premalignant changes and malignant conversion in mammary glands of transgenic mice. These changes are blocked by coexpression of a TIMP1 transgene. The premalignant and malignant lesions have stereotyped genomic changes unlike those seen in other murine mammary cancer models. These data indicate that Str1 influences tumor initiation and alters neoplastic risk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428026      PMCID: PMC2853255          DOI: 10.1016/s0092-8674(00)81009-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  60 in total

1.  Expression of vimentin by rabbit corneal epithelial cells during wound repair.

Authors:  N SundarRaj; J D Rizzo; S C Anderson; J P Gesiotto
Journal:  Cell Tissue Res       Date:  1992-02       Impact factor: 5.249

2.  Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice.

Authors:  K B DEOME; L J FAULKIN; H A BERN; P B BLAIR
Journal:  Cancer Res       Date:  1959-06       Impact factor: 12.701

3.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

4.  Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction.

Authors:  W Domagala; J Lasota; J Bartkowiak; K Weber; M Osborn
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

5.  The collagenase gene family in humans consists of at least four members.

Authors:  D Muller; B Quantin; M C Gesnel; R Millon-Collard; J Abecassis; R Breathnach
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

6.  Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma.

Authors:  E S Wargotz; H J Norris
Journal:  Hum Pathol       Date:  1989-07       Impact factor: 3.466

7.  Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues.

Authors:  L Borsi; B Carnemolla; G Nicolò; B Spina; G Tanara; L Zardi
Journal:  Int J Cancer       Date:  1992-11-11       Impact factor: 7.396

8.  Mapping of the oncogenes Myc, Sis, and int-1 to the distal part of mouse chromosome 15.

Authors:  S Adolph; C R Bartram; H Hameister
Journal:  Cytogenet Cell Genet       Date:  1987

9.  Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression.

Authors:  L E Ostrowski; J Finch; P Krieg; L Matrisian; G Patskan; J F O'Connell; J Phillips; T J Slaga; R Breathnach; G T Bowden
Journal:  Mol Carcinog       Date:  1988       Impact factor: 4.784

10.  Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution.

Authors:  R S Talhouk; M J Bissell; Z Werb
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

View more
  287 in total

1.  Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.

Authors:  L Guedez; A J McMarlin; D W Kingma; T A Bennett; M Stetler-Stevenson; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

Review 3.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 4.  Order and disorder: the role of extracellular matrix in epithelial cancer.

Authors:  Derek Radisky; John Muschler; Mina J Bissell
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

Review 5.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

6.  Matrix compliance and RhoA direct the differentiation of mammary progenitor cells.

Authors:  Cecillia Lui; KangAe Lee; Celeste M Nelson
Journal:  Biomech Model Mechanobiol       Date:  2011-12-10

7.  Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation.

Authors:  T Kirchner; T Brabletz
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

8.  Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT).

Authors:  Laurence Blavier; Alisa Lazaryev; Xiang-He Shi; Frederick J Dorey; Gregory M Shackleford; Yves A DeClerck
Journal:  Cancer Biol Ther       Date:  2010-07-29       Impact factor: 4.742

Review 9.  The difficulty of targeting cancer stem cell niches.

Authors:  Mark A LaBarge
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

10.  Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth.

Authors:  Annette Lebeau; Claudia Müller-Aufdemkamp; Clarissa Allmacher; Ulrich Sauer; Andreas Nerlich; Ralf Lichtinghagen; Udo Löhrs
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.